SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter
Advanced Science · 2024-08 · 11 (32)
DOI: 10.1002/advs.202405332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.06.2024. Verfasst von Xin Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell Proliferation, STAT3 Transcription Factor, Radiation Tolerance. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Radiotherapy is essential for treating colorectal cancer (CRC), especially in advanced rectal cancer. However, the low radiosensitivity of CRC cells greatly limits radiotherapy efficacy. Small nucleolar RNAs (snoRNAs) are a class of noncoding RNA that primarily direct post‐transcriptional modifications of ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), and other cellular RNAs. While snoRNAs are involved in tumor progression and chemoresistance, their association with radiosensitivity remains largely unknown. Herein, SNORA28 is shown highly expressed in CRC and is positively associated with poor prognosis. Furthermore, SNORA28 overexpression enhances the growth and radioresistance of CRC cells in vitro and in vivo. Mechanistically, SNORA28 acts as a molecular decoy that recruits bromodomain‐containing protein 4 (BRD4), which increases the level of H3K9 acetylation at the LIFR promoter region. This stimulates LIFR transcription, which in turn triggers the JAK1/STAT3 pathway, enhancing the proliferation and radioresistance of CRC cells. Overall, these results highlight the ability of snoRNAs to regulate radiosensitivity in tumor cells and affect histone acetylation modification in the promoter region of target genes, thus broadening the current knowledge of snoRNA biological functions and the mechanism underlying target gene regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiobiology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China.
- Graduate Collaborative Training Base of Academy of Military Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
- Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, 410078, China.
- Department of Colorectal Surgery, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Shenyang, 110042, China.
ORCID-Profile: Zhidong Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Zhang, H., Fan, Y., Cai, D., Lei, R., Wang, Q., Li, Y., Shen, L., Gu, Y., Zhang, Q., Qi, Z., & Wang, Z. (2024). SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter. Advanced Science, 11(32). https://doi.org/10.1002/advs.202405332
Vancouver
Liu X, Zhang H, Fan Y, Cai D, Lei R, Wang Q, et al. SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter. Advanced Science. 2024;11(32). doi:10.1002/advs.202405332
BibTeX
@article{Liu2024,
author = {Liu, Xin and Zhang, Hong and Fan, Ying and Cai, Dan and Lei, Ridan and Wang, Qi and Li, Yaqiong and Shen, Liping and Gu, Yongqing and Zhang, Qingtong and Qi, Zhenhua and Wang, Zhidong},
title = {SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {32},
doi = {10.1002/advs.202405332}
}
EUVIMED